GlaxoSmithKline PLC
XETRA:GS7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
GlaxoSmithKline PLC
XETRA:GS7
|
UK |
|
P
|
Primeenergy Resources Corp
F:PEJ
|
US |
|
H World Group Ltd
OTC:HWLDF
|
CN |
|
C
|
Coal India Ltd
BSE:533278
|
IN |
|
O
|
Oil States International Inc
XBER:OI2
|
US |
|
Cellectis SA
OTC:CMVLF
|
FR |
|
C
|
Champion Pacific Indonesia Tbk PT
XMUN:IUD
|
ID |
|
G
|
Grupo Mexico SAB de CV
SWB:4GE
|
MX |
|
V
|
Volatus Aerospace Inc
XHAM:ABB
|
CA |
|
Tinc Comm VA
LSE:0R7T
|
BE |
|
Reckitt Benckiser Group PLC
OTC:RBGLY
|
UK |
|
H
|
Hyundai Engineering & Construction Co Ltd
KRX:000725
|
KR |
|
I
|
Innate Pharma SA
SWB:IDD
|
FR |
|
Cellectis SA
PAR:ALCLS
|
FR |
Wall St Price Targets
GS7 Price Targets Summary
GlaxoSmithKline PLC
According to Wall Street analysts, the average 1-year price target for GS7 is 17.58 EUR with a low forecast of 12.29 EUR and a high forecast of 24.14 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GS7's stock price target?
Price Target
17.58
EUR
According to Wall Street analysts, the average 1-year price target for GS7 is 17.58 EUR with a low forecast of 12.29 EUR and a high forecast of 24.14 EUR.
What is the Revenue forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Operating Income forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Net Income forecast for GlaxoSmithKline PLC?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 8 years is 4%.
